Stocks Consumer discretionary HQY
NASDAQ · Consumer discretionaryHealthequity, Inc. (HQY)
Healthequity, Inc. brought in $1.4B of revenue over the twelve months to July 31, 2026, up 7.3% from a year earlier. Net income was $236.5M, a net margin of 17.4%. Operating cash flow minus capital spending left $455.1M of free cash flow in fiscal 2026. At July 31, 2026 it held $256M in cash against $931.1M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 27, 2026.
Key facts about Healthequity, Inc.
- Net worth
- Healthequity, Inc. has a market value (market cap) of $8.5B at the latest share price, and shareholders' equity of $2B on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $1.3B (+9.5% year on year), with net income of $215.2M. Over the 12 months to July 31, 2026: revenue $1.4B, net income $236.5M.
- Cash flow
- In fiscal 2026 operations brought in $457.1M of cash; after $2M of capital spending, free cash flow was $455.1M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 27, 2026 and covers the period to July 31, 2026. Open on SEC EDGAR
- Next earnings report
- Healthequity, Inc.'s next report is expected around December 2, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Healthequity, Inc. does
Healthequity, Inc. is registered with the SEC under industry code SIC 7389 (Services-Business Services, NEC). Its shares trade on NASDAQ under the ticker HQY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $1.3B | $215.2M | $2.46 | $455.1M |
| 2025 | $1.2B | $96.7M | $1.09 | $337.8M |
| 2024 | $999.6M | $55.7M | $0.64 | $241.1M |
| 2023 | $861.7M | -$26.1M | -$0.31 | $147.3M |
| 2022 | $756.6M | -$44.3M | -$0.53 | $132.1M |
| 2021 | $733.6M | $8.8M | $0.12 | $168.5M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where HQY ranks in Consumer discretionary
Dividends
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2017 | n/a | $0 | 0% |
| 2016 | n/a | $0 | n/a |
| 2015 | n/a | $50.3M | n/a |
| 2015 | n/a | $694K | n/a |
| 2013 | n/a | $0 | n/a |
Latest SEC filings
What Healthequity, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 9, 2026Executive or director change8-KHealthEquity terminated the employment of Chief Commercial Officer Michael Fiore without cause effective October 5, 2026.
- October 9, 2026Passive stake changed SCHEDULE 13G/A
- September 30, 2026Executive or director change8-KHealthEquity appointed Moody's Chief Financial Officer Noémie Heuland to its Board of Directors.
- August 27, 2026
- August 27, 2026Quarterly report 10-Q · period to July 31, 2026Revenue rose 7.6% to $350.7M versus the same quarter last year; diluted EPS $0.78 versus $0.68.
- August 27, 2026
- July 31, 2026Passive stake changed SCHEDULE 13G/A
- July 15, 2026Passive stake changed SCHEDULE 13G/A
- June 26, 2026
- June 26, 2026
What is HQY worth? A DCF from its reported cash flow
Insider trades
What the people running Healthequity, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $9.8K and sold $809.8K worth of shares in the last 90 days. Most of the selling (99%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Rajasekar SunilEVP Chief Prod & Strat Officer | Bought | 108 | $9.8K |
| October 6, 2026 | Neeleman StephenFOUNDER AND VICE CHAIRMAN, Director | Shares withheld for tax | 1,095 | $99.8K |
| October 6, 2026 | Lucania James MEVP & CFO | Shares withheld for tax | 2,822 | $257.2K |
| October 6, 2026 | Ladd DelanoEVP, General Counsel | Shares withheld for tax | 1,080 | $98.4K |
| October 6, 2026 | Fiore Michael HenryFormer EVP, CCO | Shares withheld for tax | 2,032 | $185.2K |
| October 6, 2026 | Gathright MichaelChief Customer Officer | Shares withheld for tax | 662 | $60.3K |
| September 17, 2026 | Neeleman StephenFOUNDER AND VICE CHAIRMAN, Director | Gave as a giftindirect | 1,500 | - |
| August 25, 2026 | Dillon Adrian TDirector | Exercised options | 7,632 | $248K |
Who owns HQY
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Wasatch Advisors LP13G, passive | 9.5% | July 15, 2026 |
| Vanguard Capital Management13G, passive | 5.3% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 498 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 11,277,914 | +745,520 |
| Wasatch Advisors LP | 7,960,735 | +757,801 |
| Morgan Stanley | 4,547,219 | +2,061,306 |
| Vanguard Portfolio Management LLC | 4,057,643 | -105,950 |
| Vanguard Capital Management LLC | 3,640,776 | -183,028 |
| State Street Corp | 3,241,046 | +141,149 |
| Geode Capital Management, LLC | 2,374,467 | +114,821 |
| Aqr Capital Management LLC | 1,999,209 | -93,014 |
| Dimensional Fund Advisors LP | 1,869,036 | +241,997 |
| William Blair Investment Management, LLC | 1,773,227 | +113,611 |
| Fmr LLC | 1,538,387 | +403,454 |
| Brown Advisory Inc | 1,372,624 | -40,160 |
| Clearbridge Investments, LLC | 1,296,765 | -13,207 |
| Charles Schwab Investment Management Inc | 1,188,902 | +13,563 |
| Greenhouse Funds LLLP | 1,183,024 | -74,830 |
| Geneva Capital Management LLC | 1,149,680 | -24,390 |
| Bank of America Corp | 1,146,735 | +284,727 |
| Jpmorgan Chase & Co | 1,158,837 | -24,574 |
| DAVENPORT & Co LLC | 1,087,218 | +71,784 |
| Northern Trust Corp | 1,072,119 | +35,945 |
Insiders
16 insiders reported holding 1,422,538 shares in total, about $145.3M at the last price.
| Holder | Shares |
|---|---|
| Neeleman StephenFOUNDER AND VICE CHAIRMAN, Director | 544,705408,235 held indirectly |
| Cutler ScottPresident and CEO, Director | 176,405 |
| Lucania James MEVP & CFO | 101,795 |
| Selander Robert WDirector | 89,849 |
| Ladd DelanoEVP, General Counsel | 88,974 |
| Rosner ElimelechEVP, CHIEF TECHNOLOGY OFFICER | 81,497 |
| Dillon Adrian TDirector | 62,395 |
| Rajasekar SunilEVP Chief Prod & Strat Officer | 53,405 |
| Dilsaver Evelyn SDirector | 51,085 |
| Fiore Michael HenryFormer EVP, CCO | 50,212 |
Questions about HQY
What does Healthequity, Inc. do?
Healthequity, Inc. is a company in the Consumer discretionary sector, listed on NASDAQ as HQY. Its shares trade on NASDAQ under the ticker HQY.
What is Healthequity, Inc.'s net worth?
Healthequity, Inc. has a market value (market cap) of $8.5B at the latest share price, and shareholders' equity of $2B on its balance sheet at July 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Healthequity, Inc. profitable?
Yes. Over the twelve months to July 31, 2026 it reported net income of $236.5M on revenue of $1.4B, a net margin of 17.4%.
How much revenue does Healthequity, Inc. make?
Over the twelve months to July 31, 2026 Healthequity, Inc. reported revenue of $1.4B. That is 7.3% more than a year earlier.
When did Healthequity, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 27, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the insider trade from October 19, 2026.
When is Healthequity, Inc.'s next earnings report?
Healthequity, Inc.'s next report is expected around December 2, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare HQY with
Follow HQY
Get an email when Healthequity, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Healthequity, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.